Financial Statements Notes to the Group Accounts 1.
Segmental analysis The Groups sales, marketing and research activities are organised into four global market sectors, being Personal Care, Life Sciences, Performance Technologies and Industrial Chemicals.
These are the segments for which summary management information ispresented to the Groups Executive Committee, which is deemed to be the Groups Chief Operating Decision Maker.
A review ofeachsector can be found within the Strategic Report on pages 14 to 20.
There is no material trade between segments.
Segmental results include items directly attributable to a specific segment as well asthose that can be allocated on a reasonable basis.
Segment assets consist primarily of property, plant and equipment, goodwill, inventories and trade and other receivables.
2016 2015 m m Restated Income statement Revenue Personal Care 420.6 377.3 2 Life Sciences 292.2 223.9 Performance Technologies 402.5 354.8 2 Industrial Chemicals 128.3 125.7 Total Group revenue 1,243.6 1,081.7 Adjusted operating profit Personal Care 143.1 124.5 2 Life Sciences 82.0 75.1 Performance Technologies 66.2 56.8 2 Industrial Chemicals 6.9 7.8 Total Group operating profit before exceptional items, acquisition costs and amortisation of intangible assets arisingonacquisition 298.2 264.2 1 Exceptional items, acquisition costs and amortisation of intangible assets arising on acquisition 12.6 2.4 Total Group operating profit 285.6 261.8 1 Relates to Personal Care 0.8m 2015: 0.4m, Life Sciences 11.3m 2015: 1.9m, Performance Technologies 0.5m 2015: 0.1m and Industrial Chemicals nil 2015: nil 2 2015 sector revenue and adjusted operating profit have been restated for a reclassification of toll product from Life Sciences to Industrial Chemicals by 7.4m and 1.1m respectively.
Balance sheet Total assets Segment total assets: Personal Care 527.3 445.6 Life Sciences 315.0 283.1 Performance Technologies 389.4 312.3 Industrial Chemicals 149.8 135.1 Total segment assets 1,381.5 1,176.1 Tax assets 56.3 38.9 Cash and investments 62.0 107.7 Total Group assets 1,499.8 1,322.7 Capital expenditure and depreciation 2016 2015 m m Additions to Additions to non-current Depreciation and non-current Depreciation and assets amortisation assets amortisation Personal Care 31.4 13.0 29.8 12.1 Life Sciences 21.2 13.6 16.4 7.0 Performance Technologies 43.8 16.8 38.5 14.3 Industrial Chemicals 12.0 5.8 10.1 5.1 Total Group 108.4 49.2 94.8 38.5 Croda International Plc 98 Annual Report and Accounts 2016
